Literature DB >> 19067225

Relationship between cardiovascular risk factors and high blood pressure by community pharmacists in Spain.

Sebastián R Martínez Pérez1, Pedro D Armando, Andrea C Molina Guerra, Mercé Martí Pallarés, Fernando Martínez Martínez.   

Abstract

OBJECTIVES: The aim of this study is to determine the influence that different risk factors (age, gender, obesity, smoking, inactivity, diabetes mellitus and previous diagnosis of arterial hypertension) have on arterial pressure, and to determine the prevalence of patients that have high blood pressure and hypertension but have not received drug-treatment for arterial hypertension.
SETTING: 42 Spanish community pharmacies.
METHOD: Observational and descriptive study. Patients included in the study were over 18 years of age, not receiving pharmacological treatment for arterial hypertension and not pregnant. Two measurements of arterial pressure were taken from each patient on the first day of the study and two other measurements on a later day. The average of these four measurements was taken as the arterial pressure value for the patient. All measurements were taken in the participating community pharmacies, always by the pharmacist and following the same protocols. The measurements were noted in the patients' records along with data about the seven risk factors being studied, allowing them to be related with the patient's arterial pressure value.
RESULTS: The number of patients invited to join the study was 3,760, of whom 2,574 agreed to participate, with 2,094 completing the study. It was found that an increase in the number of risk factors led to a corresponding rise in the percentage of patients with high blood pressure and arterial hypertension. The risk of having arterial hypertension was 4.23 times higher in patients aged 65 years and over. It was also 2.88 times greater in those who had been previously diagnosed with arterial hypertension, 2.79 times higher in overweight or obese patients, 2.69 times more in diabetics and 2.22 times higher in men compared with in women. Prevalence of high blood pressure in patients not receiving pharmacological treatment for arterial hypertension was 33.6%, and prevalence of arterial hypertension was 22.8%.
CONCLUSIONS: Of the people studied, 22.8% had arterial hypertension. For the risk factors identified, those most related to the presence of arterial hypertension were, in descending order: being 65 years old or over, previous diagnosis of arterial hypertension, being overweight or obese, being diabetic and being male.

Entities:  

Mesh:

Year:  2008        PMID: 19067225     DOI: 10.1007/s11096-008-9267-7

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  30 in total

Review 1.  Evidence based treatment of hypertension. Measurement of blood pressure: an evidence based review.

Authors:  F A McAlister; S E Straus
Journal:  BMJ       Date:  2001-04-14

2.  Blood pressure measuring devices: recommendations of the European Society of Hypertension.

Authors:  E O'Brien; B Waeber; G Parati; J Staessen; M G Myers
Journal:  BMJ       Date:  2001-03-03

3.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

4.  Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study).

Authors:  Alan J Zillich; Jason M Sutherland; Patty A Kumbera; Barry L Carter
Journal:  J Gen Intern Med       Date:  2005-12       Impact factor: 5.128

5.  Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic.

Authors:  N H Lobas; P W Lepinski; P W Abramowitz
Journal:  Am J Hosp Pharm       Date:  1992-07

6.  Blood pressure control and physician management of hypertension in hospital hypertension units in Spain.

Authors:  José R Banegas; Julián Segura; Luis M Ruilope; Manuel Luque; Rafael García-Robles; Carlos Campo; Fernando Rodríguez-Artalejo; Juan Tamargo
Journal:  Hypertension       Date:  2004-04-26       Impact factor: 10.190

7.  2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

Authors: 
Journal:  J Hypertens       Date:  2003-06       Impact factor: 4.844

8.  Effectiveness of an ambulatory care clinical pharmacist: a controlled trial.

Authors:  J D Mason; C A Colley
Journal:  Ann Pharmacother       Date:  1993-05       Impact factor: 3.154

Review 9.  Epidemiology of hypertension.

Authors:  P K Whelton
Journal:  Lancet       Date:  1994-07-09       Impact factor: 79.321

Review 10.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

View more
  1 in total

1.  Glycemic control in community-dwelling patients with type 2 diabetes.

Authors:  Yazid N Al Hamarneh; Meagen Rosenthal; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2012-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.